Open Access Journal

ISSN : 2456-1304 (Online)

International Journal of Engineering Research in Electronics and Communication Engineering(IJERECE)

Monthly Journal for Electronics and Communication Engineering

Open Access Journal

International Journal of Science Engineering and Management (IJSEM)

Monthly Journal for Science Engineering and Management
Call For Paper : Vol 11, Issue 08, August 2024

ISSN : 2456-1304 (Online)

Call for Paper

Vol 11, Issue 08, August 2024

Indexing

Effects of Vitamin E in Hypertensive Disorder of Pregnancy and Its Outcomes

Author : Binod Chaudhary 1 Jifang Shi 2

PDF

Date of Publication :10th September 2022

Abstract: Objective: To investigate the effects of vitamin E in Hypertensive Disorder of Pregnancy and the effects of vitamin E in Pregnancy Outcomes in Hypertensive Disorder of Pregnancy. Study Design: Prospective Cohort Study Materials and Method Data source: A total of 1910 pregnant women visited to the OPD and admitted in the Obstetrics and Gynecology Department of the First Affiliated Hospital of Dali University in Yunnan Province from June 2017 to May 2018 fulfilling the inclusion criteria were included in our study group. Case selection: All the pregnant women between the ages 23 to 35 years were included in the study and were divided into four groups: Normal pregnant group, gestational hypertension group, Pre-eclampsia group, and severe Pre-eclampsia group. Control group: Normal pregnant women were included in this group. Statistical Method: This study was performed prospectively and collected data were statistically analyzed using SPSS software (version 20.0) using independent t-test, Pearson Chi-square test, and one-way ANOVA test. The P values considered significant at value P<0.05. The descriptive data were presented using frequency and percentage. Multivariate Logistic regression analysis was conducted to examine the effect of vitamin E in HDP and Pregnancy outcomes including PPH, HIE, Neonatal rescue and 1≤Apgar Score≤7. Results: 1. There was no statistically significant difference in the results of all studies on BMI, WOG in the third trimester, parity, and maternal age (P>0.05). 2. Analysis between the effect of vitamin E and Hypertensive Disorder of Pregnancy: 2.1.1. There was no significant difference between the hypertensive group and control group during pregnancy in vitamin E level (t=1.665 P=0.096) (P>0.05). 2.1.2. The difference between pre-eclampsia and severe pre-eclampsia group was statistically significant in vitamin E level (t=27.692 P=0.000) (P<0.05). 2.2. Analysis between the effect of vitamin E levels and Hypertensive Disorders of pregnancy: 2.2.1. When vitamin E was excess, there was no significant difference between the control group, the gestational HTN group, pre-eclampsia group and severe pre-eclampsia group (X2 =0.164, P=0.983) (P>0.05). 2.2.2. When vitamin E was deficient, the difference between the control group and the hypertensive group during pregnancy was statistically significant (X2 =20.580, P=0.00) (P <0.05). 2.2.3. When vitamin E was deficient, there was no significant difference between the pre-eclampsia group and severe pre-eclampsia group (X2 =0.827, P=0.399) (P>0.05). 3. Effects of vitamin E in Pregnancy Outcomes in Hypertensive Disorders of pregnancy: When vitamin E level was deficient ： In Gestational Hypertension group there is 8.3% occurrence of PPH, 8.3% newborn has HIE. In pre-eclampsia group, there is 10% occurrence of PPH, 5% newborn has HIE, 5% newborn needed neonatal rescue and 5% newborn has 1≤Apgar Score≤7. In severe pre-eclampsia groups there is 5.7% occurrence of PPH, 5.7% newborn has HIE, 5.7% newborn needed neonatal rescue and 2.9% newborn has 1≤Apgar Score≤7. (X2 =2.325, P=0.887) (P> 0.05) There was no significant difference in the incidence of 1≤Apgar Score≤7 and Neonatal rescue between the pre-eclampsia and the severe pre-eclampsia. Conclusion: 1. Vitamin E contents are related to the hypertensive disorder of pregnancy. 2. Vitamin E deficiency is related to the occurrence of hypertensive disorders of pregnancy and has effects on maternal health and fetal outcomes. 3. Serum levels of vitamin E detection during pregnancy can help in the prediction of HOP; hence, it can help to reduce the risk of Pre-eclampsia.

Reference :

    1. Robert JM, Speer P. Antioxidant therapy to prevent preeclampsia. Semin Nephrol 2004;24:557-64.
    2. Zhang Chao Multivariate Analysis of Expected Treatment and Pregnancy Outcome of Early Onset Severe Preeclampsia
    3. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia.Number 33. January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 2002;77:67-75
    4. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI Working Group on Research on Hypertension during pregnancy. Hypertens Pregnancy 2003;22:109-27.
    5. Geographic variations in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am j Obstet Gynecol 1988;158;80-3.
    6. Macky AP, Berg CJ, Atrash HK. Pregnancy-related mortality from pre-eclampsia and eclampsia. Obstet Gynecol 2001;97:533-8.
    7. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of pre-eclampsia and eclampsia. No 33. January 2002Obstet Gynecol2002;99:159-67.
    8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183: S1-22.
    9. Poston L, Chappell LC. Is oxidative stress involved in the etiology of pre-eclampsia? Acta Paediatr Suppl 2001;90:3-5.
    10. Raijmakers MT, Dechend R, Poston. Oxidative stress and Preeclampsia: rationale for antioxidant clinical trials. Hypertension 2004;44:374-80.
    11. Vitamin E in Preeclampsia. MRFU, Division of Reproductive Health Endocrinology and Development, St Thomas Hospital. The United Kingdom. Ann N Y Acad Sci 2004 Dec. 1031:242-8.
    12. New Therapies in the prevention of pre-eclampsia. Spinnato.JA, 2nd Curr Opin Obstet Gynecol 2006 Dept of Obs Gyn.
    13. The pathological basis for the prophylaxis of Preeclampsia through Early Supplementation with Antioxidant vitamins. Rodrigo R, et, al. Pharmacol Ther. 2005 Aug;107(2):177-97.
    14. Subclinical infection as a cause of inflammation in Preeclampsia.Am J Ther. 2008 Jul-Aug;15(4):373-6.doi:10.10971MJT.0b013e318164c149, Vilano Group, Research Institute, Colombia.
    15. Update in Preeclampsia. Maternal-Fetal Medicine Unit, Faculty of Medicine, Chiang Mai University, Thailand. JM Assoc Thai 2004 Oct;87 Suppl 3:s104-12.
    16. Wang Liqun, Yanghong, Clinical Analysis of 28 cases of Pregnancy-induced Hypertension Disease in Plateau Area Menhua Journal of General Medicine 2011:02(08):401-510.
    17. Qiao Fuyuan, Wu Yuanyuan, Current Situation and Progress of Etiology of Hypertensive Disease in Pregnancy, Manhua Journal of Traditional Chinese Medicine, 205:29(6):339-400.
    18. Deluca, HF.(2004).Overview of general physiologic features and functions of vitamins. American Journal of Clinical Nutrition, 80(6), Supply,16859.
    19. Brown MA, Lindheimer MD, de Sweet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorder of pregnancy. Hypertens Pregnancy 2001;20: IX-XIV.
    20. Poston L Briley ALSeed PT et al. Vitamin C and Vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial[J].Lancet, 2006, 367(9517):1145-1154.
    21. James MRLeslie M Catherine Y Set al. Vitamin C and E to prevent complications of pregnancy-associated hypertension [J] The Engl J Med.2010.362(4):1282-1291.
    22. Department of Obstetrics and Gynecology, University of Adelaide, Women’s and Children’s Hospital,.72 King Williams Road, North Adelaide, SA, Australia 5006.Alice rumbold@adelaide.edu.an.
    23. Could antioxidant supplementation prevent pre-eclampsia? Holmes VA et, al. Proc Nutr Soc 2005., Queens University Belfast UK. Proc Nutr Soc. 2005 Nov; 64(4):491-501.
    24. Antioxidant therapy to prevent pre-eclampsia. Roberts JM et, al. Magee-Women’s Research Institute, Pittsburgh, PA 15213, USA. Semin Nephrol 2004 Nov: 24(6):557-64.
    25. Current Concepts in the use of the antioxidants for the treatment of preeclampsia.J Obstet Gynaecol Can: 2003 Sep;25(9):742-50.Department of Obstetrics and Gynecology Laval University and CHUL Research Centre, Quebec, QC, Canada
    26. Vitamin E and C in pre-eclampsia. Department of Biochemistry, Pt. B.D.Sharma PGIMS, Rohtak, India. Eur J Obstet and Gynecol Reprod Biol. 2000 Nov; 93(1):37-9.
    27. Effects of antioxidants in women with increased risk of pre-eclampsia; The role of oxidative stress in pre-eclampsia. Gicheva M, et al. Akash Ginekol Sofia 2004;43(1):62-4.
    28. Is oxidative stress involved in the etiology of pre-eclampsia? Acta Paediatr Suppl.2001 Mar; 90(436):3-5. Dpt of Obs Gyn. Guys Kings and St. Thomas School of Medicine, St Thomas Hospital, London, UK.
    29. WHO Guideline: Vitamin E supplementation in pregnancy.
    30. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2(9):656-663.
    31. Lucy C Chappell MB, Paul T Seed MSc et al. Effects of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial.https://doi.org/10.1016/S0140-6736(99)80010-5.
    32. Simmi Kharb, Vitamin E and C in pre-eclampsia.European Journal of Obstetrics and Gynecology and Reproductive Biology 93(1_, 37-39,2000.
    33. Judi A Turner. Diagnosis and management of pre-eclampsia: an update. International journal of women’s health 2,327,201.
    34. Sushil K Jain, Rodney Wise. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in pre-eclampsia. Molecular and cellular biochemistry 151(1), 33-38, 1995.
    35. Scott W Walsh. Lipid peroxidation in pregnancy. Hypertension in pregnancy 13(1),1-32,1994.
    36. Peter M Tiidus, Michael E Houston. Vitamin E status and response to exercise training. Sports Medicine 20(1), 12-23,1995.
    37. Graham J Burton, Eric Jauniaux. Oxidative stress. Best practice and Research Clinical Obstetrics and Gynecology 25(3),287-299,2011.
    38. Rhian M Touyz, Ana M Briones. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertension research 34(1),5,2011.
    39. von Dadelszen P, Firoz T, Don may F, Gordon R, Hofmeyr GJ, Lalami S, et al. Preeclampsia in low and middle-income countries-health services lesson learned from the PRE-EMPT(PRE-Eclampsia-Eclampsia M0nitoring, Prevention, and Treatment)Project J Obstet Gynecol Can 2012;34(10):917-26.
    40. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnemborg R. Preeclampsia. Lancet2010:376(9741):631-44.
    41. Centre for Maternal and Child Enquiries(CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report on Confidential Inquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl)S1-S48.
    42. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe pre-eclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol2005:105:246-54.
    43. Redman CWG. The placenta, pre-eclampsia and chronic villitis. In: Redman CWG, SergentILSP, editors. The human placenta. Oxford: Blackwell Scientific; 1993.p. 433-67.
    44. BasChat AA. Pathophysiology of Fetal growth restriction: implications for diagnosis and surveillance. Obstet Gynecol Surv2004;59:617-27

Recent Article